November 16, 2026

Annual Literature Review vs. Continuous Literature Monitoring: Which Fits Your Research Rhythm?

A clinician preparing a research update often faces the same fork: run one comprehensive search once a year, or keep a quieter feed running all year. The two approaches feel interchangeable at first, but they differ in w

Written byWisPaper TeamAI Research Workflow Team
Editorial illustration for Annual Literature Review vs. Continuous Literature Monitoring: Which Fits Your Research Rhythm?

A clinician preparing a research update often faces the same fork: run one comprehensive search once a year, or keep a quieter feed running all year. The two approaches feel interchangeable at first, but they differ in what they catch, how fast they catch it, and what they ask of you between searches. The deciding question is not which method is better; it is which failure you can afford. An annual review risks missing a trial that would have changed your conclusion for months. A continuous monitor risks piling up duplicates and marginal findings that dilute your attention. Many teams end up needing both in sequence: continuous monitoring to keep a project warm, an annual review to reset the record and prepare a defensible document.

This guide works through both options on the same evidence task: a cardiology researcher tracking anticoagulation strategies for atrial fibrillation among adults aged 75 and older across one calendar year. We compare how each mode behaves at search planning, screening, deduplication, and reporting, then show where a combined workflow helps. Throughout, the language stays at the level of evidence rather than tools: the aim is to distinguish a direct, well-conducted study from an indirect or limited one, not simply to count hits.

Where Are You Now: A Single Push or a Year-Long Rhythm?

Start by locating your actual bottleneck before choosing a mode. If your group meets once a year to renew a guideline paragraph, the deliverable is a snapshot. If you maintain a living summary that front-line staff read weekly, the deliverable is a stream. A common misdiagnosis is to adopt continuous monitoring because the annual search felt rushed last time. The rush may have come from poor handoff, not from the annual cadence itself.

For the anticoagulation example, the snapshot task is one scripted search run in November, followed by a screened set of studies and a one-page summary of what changed since last year. The streaming task is the same search saved and re-run monthly, with only newly indexed or newly updated records reviewed. Both tasks start with the same eligibility criteria. The Cochrane Handbook's guidance about planning searches from eligibility criteria, using multiple sources, documenting the process, deduplicating records, and screening in stages applies to both, but the discipline shows up differently in each rhythm.

What Makes a Literature Review Defensible, Whether Annual or Continuous?

A defensible review is one you could rebuild from the record alone. That means the eligibility criteria are written before the search, the sources are named, the deduplication step is explicit, and the screening decisions are tracked. The Cochrane Handbook's description of deduplicating records and linking reports of the same study is the key safeguard here: a single trial can appear as a protocol, a conference abstract, and a journal article. If you treat those as three separate findings, your headline count is wrong even when your search was excellent.

This is also where persistent identifiers become practical. A DOI remains stable when the location or descriptive record of a scholarly object changes, so it gives you a dependable way to link the versions of one study without relying on matching by title strings. In continuous monitoring, where the same article can surface month after month in slightly different forms, that linkage is what prevents your review from silently overcounting. It does not make a study stronger; it makes your accounting cleaner.

Annual Review: What the Single Push Optimizes For

The annual review optimizes for a clean boundary and a shared verdict. Because everything is screened in a short window, two people can usually compare their inclusion decisions directly. The search can be fully re-run and re-documented shortly before your deadline, which addresses the Cochrane practice of updating searches before publication. In our anticoagulation example, the annual cycle lets you freeze the record on a date, say the last day of October, and say clearly which version of each trial entered the evidence base.

The main failure mode is an unfrozen window. If the search results keep drifting in while the screeners are halfway through, the process quietly becomes continuous monitoring without its safeguards. A second failure is compression: the search may be excellent, but the screening gets squeezed into the last ten days, and the deduplication step is skipped because it feels like housekeeping. The result is a snapshot that is not actually a snapshot.

For most teams, the annual review works well as a reset. Before beginning a full re-search, the practical step is to route your existing references into one clean, organized space. My Library is useful at that point for saving or uploading the papers your team already holds, so the new search has a clear prior set to compare against. The reset matters less because the tool is fancy and more because a visible prior set exposes what the new search should add.

Continuous Monitoring: What the Persistent Feed Optimizes For

Continuous monitoring optimizes for interval between publication and awareness. When a new trial appears, the delay is bounded by your re-run schedule rather than by your annual calendar. For a topic like anticoagulation in older adults, where one trial outcome can shift practice discussion, that timeliness can be the point of the exercise. The monitor does not need to be a full re-review every month; it needs a stable query, a narrow alert window, and a rule for what qualifies as worth discussing.

The main failure mode is alert fatigue. If every monthly run returns thirty records and most are duplicates or abstracts already seen, the monitor stops being read, which means the one important study sits in an unread email. A second failure is drifting eligibility. Because the reviewer is making quick calls in small batches across the year, inclusion criteria can slowly stretch without anyone noticing. The annual review, for all its gaps, forces a full re-statement of the rules at least once.

For teams that want to keep the feed warm between annual resets, WisPaper Search is the natural place to find academic papers through a scholarly search interface while the question is still active. The search itself is a search; what makes continuous monitoring sustainable is what you do with the results a month later.

Same Task, Two Rhythms: A Side-by-Side Run

Consider our focused population: adults 75 and older with nonvalvular atrial fibrillation, and the outcome of ischemic stroke over twelve months. A direct study is one that enrolls that population, reports that outcome, and follows patients for at least that horizon. An indirect one might enroll a younger median age, report only a composite including bleeding, or measure a surrogate like time in therapeutic range. A limited one might have a small sample even when it is otherwise on target.

Under an annual model, the November search returns a manageable set. Two reviewers screen titles, then abstracts, then full texts. They deduplicate and link the protocol, abstract, and full report of one trial. They classify each included study as direct or indirect, and they state how the indirect ones bear on the clinical question. The summary reads like a brief: what changed, how strong it is, and what remains unknown.

Under a continuous model, the same search runs monthly. One reviewer screens each batch against the written criteria, and anything ambiguous is parked for the next team meeting. The risk is that the ambiguous pile grows faster than the meetings resolve it. The advantage is that when a new trial appears in March, the team discusses it in April, not at the year-end meeting in January. The evidence base stays current, but the cost is a standing screening role rather than a burst of effort.

The Decision Table: Which Mode Fits This Quarter?

ConditionPrefer annual reviewPrefer continuous monitoring
The task feeds a fixed report, guideline paragraph, or year-end briefingYesNo
A new trial could change practice within weeksNoYes
Team attention is concentrated in a short windowYesNo
A standing reviewer can process small batches monthlyNoYes
Deduplication and version linkage are part of the planYesYes
The previous review left a messy, unfrozen recordYes, as a resetOnly after the reset is clean

The last row is the one teams most often miss. Continuous monitoring layered on top of a messy library does not modernize the review; it automates the mess. If the prior year ended with unreliable counts, the next best move is an annual-style reset first, then continuous monitoring on a clean foundation.

A Combined Workflow That Produces a Defensible Brief

The practical pattern for many research groups is not a choice between the two but a rhythm that uses both. Keep a monthly monitor active with a narrow query and a written triage rule. Keep a shared table of new records, each with its source, DOI, screening decision, and a note on why an indirect study is indirect. Then, once a year, run the full search again, re-document everything, deduplicate across the whole year, and produce the summary.

That annual pass is the moment to move from collection to synthesis in one place. Research Projects can hold that year-end effort as a distinct project, so the evidence brief, the screening log, and the source records sit together rather than scattered across email threads. The project container does not do the synthesis for you; it gives the synthesis a stable address.

Before the brief circulates, a focused quality pass on the citation list is worth the time. The screening can be careful and the conclusions can still be undermined by a reference that does not point to a real, findable study. TrueCite checks BibTeX against academic databases to flag hallucinated references, which is exactly the kind of error that creeps in when references are typed from memory or copied from a secondary list. This step belongs near the end, after the evidence content is settled and before the brief leaves your desk.

How to Know the Result Is Ready

A literature review is ready when each of four statements can be checked against a visible record. First, the search is reproducible: the criteria came first, the sources are named, and the date window is explicit. Second, the counts are clean: duplicates are removed, and the versions of one study are linked through a persistent identifier such as a DOI. Third, the screening is staged and documented, not reconstructed after the fact. Fourth, the conclusions distinguish a direct study from an indirect or limited one, and they do not rest on evidence that carried a different population or a different outcome.

For the anticoagulation brief, readiness means you can show why a trial that enrolled mostly younger participants received a lower evidential weight, not just that some trials were excluded. It means the March alert that turned out to be an old conference abstract is linked to the full trial report rather than counted as a new finding. It means the summary states what changed over the year without implying the evidence is stronger than the study designs allow.

FAQs

Not usually, because the two produce different artifacts. Continuous monitoring keeps the time gap short between publication and awareness, but it rarely forces the full re-statement of eligibility criteria, deduplication, and version linkage that an annual review does. A clean sequence is to run the monitor all year, then run the annual review as the consolidation pass that turns twelve months of alerts into one documented, deduplicated evidence brief.